CXCL10 antagonism and plasma sDPPIV correlate with increasing liver disease in chronic HCV genotype 4 infected patients
Men and women older than 30 years
Prevalence of normal Coronary Arteries by Coronary Computed Tomography Angiography (CCTA) in Patients with Type 2 Diabetes Mellitus from Semaglutide Treatment on Coronary Plaque Progression (STOP) Trial
Ganorkar stated, "Improving access to GLP-1 treatments in the coming years may be a key driver for the Indian pharmaceutical industry, helping address the growing burden of lifestyle diseases such as obesity and diabetes." He noted that combining these treatments with AI-enabled digital tools for early disease detection, monitoring, and personalized medicine choices could drive innovation focused on accessibility, affordability, and better patient outcomes
These bypass the healthcare system entirely
Your dedicated weight loss team will work side by side you and your family, customizing a weight loss plan to fit your goals and your timeframe